Ingredient

Terazosin Hydrochloride Hydrate

Terazosin hydrochloride hydrate is a medication that alleviates urinary symptoms caused by benign prostatic hyperplasia.

See medicines used for Chronic Conditions
All medicines
43
Single ingredient
43
Prescription medication
43

MFDS ingredient code M250456

What does it do?

Terazosin hydrochloride hydrate belongs to the class of alpha-1 adrenergic receptor blockers. It is primarily used in medications to improve urination dysfunction in patients with benign prostatic hyperplasia. It relaxes the muscles of the urinary tract to facilitate urine flow.

This ingredient blocks the alpha-1 receptors around the prostate and bladder neck, relaxing the muscles. As a result, it widens the urinary tract to help urine flow better. Consequently, symptoms such as urinary difficulty are alleviated.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Terazosin hydrochloride hydrate has blood pressure-lowering effects compared to other alpha-1 blockers; however, it is effective in improving urological symptoms. This ingredient is particularly specialized for the treatment of benign prostatic hyperplasia, distinguishing it from similar class medications.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

43 total

View more

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.